NCT06601465View on ClinicalTrials.gov

COgnitioN With VERiciGuat Evaluation in Heart Failure

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 3, 2025

Primary Completion Date

July 31, 2026

Study Completion Date

May 31, 2027

Conditions
Heart FailureCognitive Impairment
Interventions
DRUG

Vericiguat

Tablet - 2.5 mg, 5 mg, 10 mg

Trial Locations (4)

Unknown

RECRUITING

University of Calgary, Calgary

RECRUITING

University of Alberta, Edmonton

RECRUITING

University of Ottawa, Ottawa

NOT_YET_RECRUITING

McGill University Health Center, Montreal

All Listed Sponsors
collaborator

Ottawa Heart Institute Research Corporation

OTHER

collaborator

Heart and Stroke Foundation of Canada

OTHER

lead

University of Alberta

OTHER

NCT06601465 - COgnitioN With VERiciGuat Evaluation in Heart Failure | Biotech Hunter | Biotech Hunter